UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5227

2023

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor cells and their role in prostate cancer

Asian journal of andrology, 2019-01, Vol.21 (1), p.24-31

2019

Link zum Volltext

Verfügbarkeit prüfen

A Peritoneal Purse-String Suture Prevents Symptomatic Lymphoceles in Retzius-Sparing Robot-Assisted Radical Prostatectomy

Journal of clinical medicine, 2023-01, Vol.12 (3), p.791

2023

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette-Guérin (BCG) Therapy

Cancers, 2024-04, Vol.16 (7), p.1356

2024

Link zum Volltext

Verfügbarkeit prüfen

Urothelkarzinom der Harnblase

Uro-news, 2021-10, Vol.25 (10), p.34-43

2021

Link zum Volltext

Verfügbarkeit prüfen

A Protocol for Organoids from the Urine of Bladder Cancer Patients

Cells (Basel, Switzerland), 2023-08, Vol.12 (17), p.2188

2023

Link zum Volltext

Verfügbarkeit prüfen

Re: Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma

European urology, 2021-08, Vol.80 (2), p.257-258

2021

Link zum Volltext

Verfügbarkeit prüfen

Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer

Asian journal of andrology, 2019-01, Vol.21 (1), p.12-18

2019

Link zum Volltext

Verfügbarkeit prüfen

Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?

Disease markers, 2018-01, Vol.2018, p.5823870-5

2018

Link zum Volltext

Verfügbarkeit prüfen

Molecular predictors of response to PD-1/PD-L1 inhibition in urothelial cancer

World journal of urology, 2019-09, Vol.37 (9), p.1773-1784

2019

Link zum Volltext

Verfügbarkeit prüfen

Can urinary biomarkers replace cystoscopy?

World journal of urology, 2019-09, Vol.37 (9), p.1741-1749

2019

Link zum Volltext

Verfügbarkeit prüfen

Should every patient with muscle-invasive bladder cancer receive neoadjuvant chemotherapy?

Translational andrology and urology, 2019-07, Vol.8 (Suppl 3), p.S274-S276

2019

Link zum Volltext

Verfügbarkeit prüfen

Urine biomarkers in bladder cancer - current status and future perspectives

Nature reviews. Urology, 2023-10, Vol.20 (10), p.597-614

2023

Link zum Volltext

Verfügbarkeit prüfen

Enfortumab vedotin - next game-changer in urothelial cancer

Expert opinion on biological therapy, 2021-07, Vol.21 (7), p.801-809

2021

Link zum Volltext

Verfügbarkeit prüfen

Radical Transurethral Resection of Bladder Tumor in Seemingly Organ-confined Muscle-invasive Bladder Cancer: Con

European urology focus, 2023-03, Vol.9 (2), p.223-224

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies

World journal of urology, 2022-05, Vol.40 (5), p.1175-1183

2022

Link zum Volltext

Verfügbarkeit prüfen

Retrospective German claims data study on initial treatment of bladder carcinoma (BCa) by transurethral bladder resection (TURB): a comparative analysis of costs using standard white light- (WL-) vs. blue light- (BL-) TURB

World journal of urology, 2021-08, Vol.39 (8), p.2953-2960

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the metabolome in urine prior and eight weeks after radical prostatectomy uncovers pathologic and molecular features of prostate cancer

Journal of pharmaceutical and biomedical analysis, 2021-10, Vol.205, p.114288-114288, Article 114288

2021

Link zum Volltext

Verfügbarkeit prüfen

Expression of tumour progression‐associated genes in circulating tumour cells of patients at different stages of prostate cancer

BJU international, 2018-07, Vol.122 (1), p.152-159

2018

Link zum Volltext

Verfügbarkeit prüfen

Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?

World journal of urology, 2021-11, Vol.39 (11), p.4021-4027

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of somatostatin receptor expression in advanced bladder cancer

Urologic oncology, 2020-12, Vol.38 (12), p.935.e17-935.e28

2020

Link zum Volltext

Verfügbarkeit prüfen

Bone Health Issues in Patients with Prostate Cancer: An Evidence-Based Review

The world journal of men's health, 2020-04, p.151-163

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer

Expert review of molecular diagnostics, 2018-05, Vol.18 (5), p.443-455

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(40)
Humans
(24)
Urology & Nephrology
(17)
Male
(11)
Patients
(11)
Bladder Cancer
(9)
Tumors
(9)
Female
(8)
Oncology
(8)
Medicine & Public Health
(7)
Medicine, Research & Experimental
(7)
Metastasis
(7)
Research & Experimental Medicine
(7)
Biotechnology & Applied Microbiology
(6)
Diagnosis
(6)
Medicine
(6)
Nephrology
(6)
Prostate Cancer
(6)
Treatment Outcome
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

World Journal Of Urology
(5)
Expert Opinion On Biological Therapy
(4)
Bju International
(3)
Asian Journal Of Andrology
(2)
Circulation
(2)
Disease Markers
(2)
European Urology Focus
(2)
Scientific Reports
(2)
Aerospace
(1)
Annals Of Surgery
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases

Circulating tumor cells and their role in prostate cancer

A Peritoneal Purse-String Suture Prevents Symptomatic Lymphoceles in Retzius-Sparing Robot-Assisted Radical Prostatectomy

PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette-Guérin (BCG) Therapy

Urothelkarzinom der Harnblase

A Protocol for Organoids from the Urine of Bladder Cancer Patients

Re: Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma

Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer

Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?

Molecular predictors of response to PD-1/PD-L1 inhibition in urothelial cancer

Can urinary biomarkers replace cystoscopy?

Should every patient with muscle-invasive bladder cancer receive neoadjuvant chemotherapy?

Urine biomarkers in bladder cancer - current status and future perspectives

Enfortumab vedotin - next game-changer in urothelial cancer

Radical Transurethral Resection of Bladder Tumor in Seemingly Organ-confined Muscle-invasive Bladder Cancer: Con

Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies

Retrospective German claims data study on initial treatment of bladder carcinoma (BCa) by transurethral bladder resection (TURB): a comparative analysis of costs using standard white light- (WL-) vs. blue light- (BL-) TURB

Comparison of the metabolome in urine prior and eight weeks after radical prostatectomy uncovers pathologic and molecular features of prostate cancer

Expression of tumour progression‐associated genes in circulating tumour cells of patients at different stages of prostate cancer

Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancer

The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer

Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?

Prognostic impact of somatostatin receptor expression in advanced bladder cancer

Bone Health Issues in Patients with Prostate Cancer: An Evidence-Based Review

Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer

Suchergebnisse filtern